Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who ...
CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Targeted Oncology6 天
Emerging TRK Inhibitors Are Explored Across Cancer Settings
Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...